Journal article
EBV DNA: a Hodgkin lymphoma biomarker?
Abstract
In this issue of Blood, Kanakry and colleagues report that increased pretreatment levels of plasma Epstein Barr virus DNA (EBV-DNA), as determined by quantitative real-time polymerase chain reaction (QRT-PCR), are associated with inferior outcomes among patients with previously untreated, advanced-stage Hodgkin lymphoma.
Authors
Meyer RM
Journal
Blood, Vol. 121, No. 18, pp. 3541–3542
Publisher
American Society of Hematology
Publication Date
May 2, 2013
DOI
10.1182/blood-2013-02-484451
ISSN
0006-4971